THREAD

What THREAD does

THREAD is a private, PE-backed clinical research technology company that provides a unified, no-code SaaS platform enabling pharmaceutical sponsors, biotech firms, contract research organizations (CROs), academic medical centers, and medical device companies to run decentralized (DCT), hybrid, or site-based clinical trials across 60+ countries and 100+ languages. The platform consolidates 12 clinical trial technology categories — including eConsent, eCOA/eDiaries, telehealth virtual visits, eCRFs/eSource, recruitment and onboarding, voice/image/video capture, device and sensor integrations, engagement and retention, real-time analytics, RWD tokenization, configurable SSO, and configurable data reporting — into a single configurable environment hosted on AWS infrastructure. Differentiated capability modules include inVibe voice-powered patient listening (22,000+ patient/HCP insights), a 545+ instrument eCOA library, 300+ pre-built device/sensor integrations, and AI features (GPT-powered Smart Summary, Playground, and an AI Moderator that runs real-time qualitative interviews). THREAD also offers consulting services (THREAD DESIGN for study enablement and Modus Outcomes for patient-centered outcomes research) and has been recognized as a Leader in Everest Group's DCT PEAK Matrix for three consecutive years (2021-2023) and as an IDC MarketScape Leader (2022).

The company generates revenue primarily through annual or multi-year enterprise SaaS subscriptions sold via direct field sales to pharma sponsors and CROs, augmented by professional services (study design, endpoint strategy, regulatory advisory, linguistic validation, device provisioning), eCOA instrument licensing, and AWS Marketplace procurement (where customers can apply AWS EDP credits). Pricing is quote-based and not publicly disclosed. THREAD sells primarily through direct enterprise sales supported by inside sales, channel partners (RQM+, UBC, MMS, Cogstate, 3H Medi Solution for Japan, SAS, Trialbee, 1nHealth), strategic integrations (Datavant, SEQSTER, EVERSANA, AWS), and event-driven demand generation at clinical research conferences. The company is headquartered in Cary, North Carolina, with additional offices in Lyon, France and Cheltenham, UK; it was founded in 2013 (per company history; firmographic data also references 2016), acquired by Water Street Healthcare Partners and JLL Partners in August 2019, and received an additional capital commitment of up to $50 million in August 2020 to fund global expansion.

Name

THREAD

Legal name

Definitive Media Corp.

Website

https://threadresearch.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

THREAD provides a unified, no-code SaaS platform enabling pharmaceutical sponsors, biotech firms, CROs, and academic institutions to run decentralized, hybrid, and site-based clinical trials across 60+ countries, combining eCOA, eConsent, telehealth, voice-based patient listening, device integrations, and AI-powered analytics in a single configurable environment.

Ownership category

akta.pro rank

Product category

Decentralized Clinical Trial (DCT) and eCOA Technology Platform

NAICS

Computer Systems Design and Related Services (5415)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industry

Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB)

Keywords

• Decentralized clinical trials
• Electronic clinical outcome assessment
• Clinical research platform
• ECOA instruments library
• Patient listening technology

Headquarters

HQ city

Cary

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. DCT/eCOA SaaS Platform Subscription: THREAD generates primary revenue through annual or multi-year SaaS subscription contracts for access to its decentralized clinical trial platform. Contracts are typically sold to pharmaceutical sponsors, biotech companies, and CROs on an enterprise basis. Pricing is based on study scope, participant volume, and feature configuration.
2. Professional Services (Consulting and Enablement): THREAD offers paid consulting services including study design, endpoint development, site training, regulatory advisory, translation and linguistic validation, data archival, device provisioning, and audit support. These services complement the platform and are delivered by DCT experts throughout the study lifecycle.
3. eCOA Instrument Licensing: THREAD provides access to a library of 545+ pre-vetted electronic clinical outcome assessments. Revenue is generated through licensing procurement and management of assessments for use within platform-hosted studies.
4. AWS Marketplace Procurement: THREAD is available for purchase through the AWS Marketplace, enabling shared life science customers to apply AWS EDP credits against THREAD subscriptions. This creates a procurement pathway that may influence revenue timing and structure for cloud-native customers.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

THREAD provides a cloud-based, no-code decentralized clinical trial (DCT) and electronic clinical outcome assessment (eCOA) SaaS platform that consolidates 12 clinical trial technology categories—eConsent, recruitment, telehealth, eCOA/eDiaries, eCRFs/eSource, voice/image/video capture, digital health technology, engagement, analytics, APIs, SSO, and configurable reporting—into one configurable environment. The platform is sold primarily via enterprise subscriptions to pharmaceutical sponsors, biotech firms, and CROs, with operations in 60+ countries and 100+ languages, supplemented by proprietary inVibe voice capture, an eCOA library of 545+ instruments, 300+ device integrations, and consulting services including Patient-Centered Outcomes Research (PCOR).

Product overview

THREAD provides a unified, fully configurable no-code clinical research platform combining high-technology and high-science to enable decentralized, hybrid, and site-based clinical trials. The core THREAD Platform integrates 12 clinical trial technologies including eCOA/eDiaries, eConsent, Telehealth Virtual Visits, eCRFs/eSource, Device/Sensor Library, and Realtime Analytics. The platform is augmented by inVibe for voice-powered patient listening, Modus Outcomes for Patient-Centered Outcomes Research (PCOR), and THREAD DESIGN for enablement consulting services. AI capabilities include GPT-powered Smart Summary and Playground features plus AI Moderator for qualitative research interviews. The platform supports operations in 60+ countries with 100+ languages.

Differentiator

Problem solved

Functional benefit

Brands

• inVibe: Voice-powered research technology provider for patient and healthcare professional listening solutions, acquired by THREAD in January 2022.
• Modus Outcomes

Products and services

• THREAD Platform Fully configurable, no-code cloud-based SaaS platform enabling decentralized, hybrid, and site-based clinical trials. Consolidates 12 clinical trial technology categories including eCOA/eDiaries, eConsent, telehealth virtual visits, eCRFs/eSource, device/sensor library, patient engagement, voice/image/video capture, recruitment, global cloud, real-time analytics, configurable SSO, and configurable data reporting. Sold via annual/multi-year enterprise subscriptions to pharma, biotech, CROs, and academic institutions.
• inVibe Patient and HCP Listening Voice-powered patient and healthcare professional listening solution that combines automated voice-response data collection with linguistic and AI-driven analysis (including GPT-powered Smart Summary, Playground, and AI Moderator features) to capture and analyze real patient voices at scale. Delivered as a dedicated listening offering to study sponsors and commercialization teams, having gathered insights from over 22,000 unique patients and HCPs across multiple therapeutic areas.
• Patient-Centered Outcomes Research (PCOR) Services Consulting service delivered by the Modus Outcomes scientific team providing patient-centered outcome strategy including conceptual model development, endpoint selection, instrument development, and regulatory alignment. Sold as a standalone advisory engagement to sponsors developing clinical outcome assessments and regulatory submissions.
• THREAD DESIGN Enablement Services Consultative enablement service combining proprietary technology with deep regulatory knowledge to help life science organizations design, operate, and scale next-generation research studies and eCOA programs. Includes study design, endpoint development, site training, regulatory advisory, translation and linguistic validation, data archival, device provisioning, and audit support delivered by DCT experts throughout the study lifecycle.

Quantifiable outcome

• Studies supported by THREAD outperform industry benchmarks in patient recruitment and retention (case study evidence available in THREAD resources)
• +4 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability8 records

Feature12 records

Partnerships

18 partnerships are on record, tiered core, major, regional and minor.

• SEQSTERcoreTechnology or Integration · 10 June 2024THREAD and SEQSTER partnered to fast-track real-world data collection, offering biopharmaceutical companies and CROs an innovative solution to collect and integrate prospective study data with retrospective real-world data for research.
• DatavantcoreTechnology or Integration · 3 October 2023THREAD expanded its partnership with Datavant to launch a fully configurable solution for real-world data linkage. The partnership enables tokenization workflows embedded within THREAD's platform, allowing sponsors to link clinical trial data with real-world data sources while maintaining patient privacy and regulatory compliance.
• RQM+majorStrategic or Co-development Partner · 25 July 2023RQM+ selected THREAD to power its new medical device research offering, enabling RQM+ to offer THREAD's configurable DCT and eCOA platform as part of its comprehensive medical device clinical research services.
• CogstatemajorTechnology or Integration · 24 July 2023THREAD and Cogstate partnered to support CNS research by integrating Cogstate's leading cognitive testing solutions with THREAD's configurable, no-code eCOA platform, providing biopharma sponsors and CROs with a modern cognitive assessment solution.
• SASmajorStrategic or Co-development Partner · 18 July 2023SAS and THREAD launched a proprietary joint offering for biopharma companies, combining SAS's analytics capabilities with THREAD's DCT platform to provide integrated clinical research and data analytics solutions.
• University of Pittsburgh CTSImajorStrategic or Co-development Partner · 27 June 2023University of Pittsburgh CTSI partnered with THREAD to accelerate the impact of translational research, enabling academic researchers to use THREAD's platform for investigator-initiated studies and clinical research programs.
• AllucentmajorStrategic or Co-development Partner · 20 June 2023Allucent selected THREAD to power its Patient Direct Trials offering, integrating THREAD's platform into Allucent's decentralized clinical trial services for biopharma sponsors.
• 3H Medi SolutionregionalChannel Partner/ Reseller/ Distributor · 21 February 20233H Medi Solution selected THREAD to expand the delivery of decentralized clinical trials in Japan, leveraging 3H Medi Solution's local market expertise and THREAD's platform technology.
• UBC (United BioSource)majorStrategic or Co-development Partner · 27 June 2022UBC selected THREAD to launch a new SitePlus offering, combining UBC's central site model with THREAD's DCT technology to widen recruitment access and improve site and patient experience. The partnership was later expanded in 2024.
• BezylminorStrategic or Co-development Partner · 31 May 2022Bezyl, a global digital mental health company, formed a strategic partnership with THREAD to provide its mental health digital app and support system to patients participating in THREAD-enabled clinical trials, addressing participant wellbeing during studies.
• MMS HoldingsmajorChannel Partner/ Reseller/ Distributor · 24 May 2022MMS Holdings selected THREAD as partner of choice to deliver decentralized clinical trials, solidifying MMS as a full-service DCT provider from electronic data capture through completion. MMS offers THREAD's platform as part of its differentiated DCT service offering.
• Amazon Web Services (AWS)coreTechnology or Integration · 29 March 2022THREAD and AWS collaborate to advance patient-first research at enterprise scale. THREAD's DCT platform runs on AWS cloud infrastructure, integrating AI-driven automation, open APIs, data lake architecture, and configurable integrations. THREAD is available on the AWS Marketplace, enabling shared life science customers to purchase using AWS EDP credits. AWS ProServe helped build THREAD's Open and Configurable API infrastructure and data lake. THREAD has passed AWS's Foundational Technical Review (FTR) and is certified as an AWS ISV Accelerate Partner.
• EVERSANAmajorStrategic or Co-development Partner · 16 February 2022THREAD and EVERSANA announced the industry's first integrated, decentralized registry and real-world data (RWD)-driven evidence and commercialization solution, combining THREAD's platform with EVERSANA's evidence generation capabilities.
• Almac Clinical TechnologiescoreTechnology or Integration · 28 July 2021THREAD and Almac Clinical Technologies partnered to eliminate common clinical trial delays by integrating their technologies to enable more efficient clinical trials that generate better outcomes.
• UPS HealthcaremajorStrategic or Co-development Partner · 29 June 2021UPS Healthcare partnered with THREAD to deliver the first decentralized clinical trial platform with a comprehensive in-home visit solution, providing seamless digital experiences for clients and patients for decentralized clinical trials.
• TrialbeeminorChannel Partner/ Reseller/ Distributor · 4 May 2021THREAD and Trialbee partnered to enhance global DCT inclusivity and recruitment outcomes, streamlining global recruitment processes and maximizing opportunities for diverse DCT participant recruitment.
• CureClickminorChannel Partner/ Reseller/ Distributor · 11 March 2021THREAD and CureClick initially partnered to accelerate recruitment for decentralized clinical trials before THREAD acquired CureClick in April 2022, integrating CureClick's crowdsourcing network into the THREAD platform.
• 1nHealthminorChannel Partner/ Reseller/ Distributor · 2 February 2021THREAD and 1nHealth partnered to optimize participant recruitment in decentralized clinical trials, streamlining patient-centric recruitment for sponsors and CROs to improve recruitment and retention outcomes.

Scale indicators7 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• Veeva Systems: Provides CTMS, eTMF, and clinical operations solutions to life sciences sponsors through Veeva Vault Clinical. Directly competes with THREAD's clinical research platform for similar enterprise pharma/biotech customers.
• Signant Health: Specializes in eCOA, patient-centric clinical trial technology, and DCT enablement. Directly competes with THREAD's eCOA library and patient engagement modules for clinical trial sponsors and CROs.
• Oracle Health Sciences (Clinical One): Oracle's Clinical One platform provides unified eClinical and DCT capabilities including EDC, eCOA, RTSM, and direct data capture. Directly competes with THREAD's unified platform for enterprise sponsor customers.
• Medable: A DCT-focused SaaS platform offering eCOA, telehealth, eConsent, and remote monitoring for decentralized clinical trials. Directly competes with THREAD's DCT platform with a similar enterprise customer base in pharma and biotech.
• Medidata Solutions (Dassault Systèmes): A leading eClinical platform provider offering Rave EDC, eCOA, and DCT capabilities to pharma/biotech sponsors via the Medidata Platform. Directly competes with THREAD in the same product categories (eCOA, eConsent, DCT enablement) serving the same enterprise customers.
• Science 37: A DCT pure-play offering a 'Metasite' model for fully decentralized clinical trials, including telemedicine investigators and remote data capture. Directly competes with THREAD in decentralized trial enablement for large sponsors.
• Clario: A leading eCOA, imaging, and DCT solutions provider formed via the merger of ERT and BBK Worldwide. Directly competes with THREAD in eCOA and decentralized trial enablement, serving large pharma/biotech sponsors.

Broad incumbents

• IQVIA: A global CRO and life sciences technology provider offering decentralized trial services through IQVIA Decentralized Trials alongside its broader CRO and data portfolio. Competes with THREAD in DCT but as part of a much larger services-led offering.

Emerging players

• Castor: An eClinical platform offering EDC, eCOA, eConsent, and DCT capabilities with growing focus on AI-driven trial operations. Partial overlap with THREAD's platform, often serving smaller and mid-sized sponsors and academic researchers.
• ObvioHealth: An emerging DCT platform offering hybrid and fully decentralized clinical trial capabilities with virtual site services. Partial overlap with THREAD's DCT platform, primarily targeting biotech and mid-sized sponsor customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/THREADresearch
• YouTubeyoutube.com/@threadresearch
• LinkedInlinkedin.com/company/threadresearch

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about THREAD